3CCK | Immune System | date | Feb 26, 2008 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Human Cd69 | ||||||||||||||
authors | J.Brynda, O.Vanek, P.Rezacova | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Early Activation Antigen Cd69 Chain: A, B Fragment: Unp Residues 82-199 Synonym: Early T-Cell Activation Antigen P60, Gp3228, Leu- Ea1, Bl-Acp26, Activation Inducer Molecule, Aim; Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Cd69 Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_strain: Bl21 (De3) Ril Expression_system_vector_type: Plasmid | ||||||||||||||
symmetry | Space Group: P 61 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.80 Å | ||||||||||||
ligand | CL | enzyme |
| ||||||||||||
Primary reference | Soluble recombinant CD69 receptors optimized to have an exceptional physical and chemical stability display prolonged circulation and remain intact in the blood of mice., Vanek O, Nalezkova M, Kavan D, Borovickova I, Pompach P, Novak P, Kumar V, Vannucci L, Hudecek J, Hofbauerova K, Kopecky V Jr, Brynda J, Kolenko P, Dohnalek J, Kaderavek P, Chmelik J, Gorcik L, Zidek L, Sklenar V, Bezouska K, FEBS J. 2008 Nov;275(22):5589-606. PMID:18959746 |
Data retrieval |
View 3CCK in 3D |
Visual 3D analysis of 3CCK |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3CCK |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |